CliffBio
small molecule

ACETADOTE

ACETYLCYSTEINE

Loss of exclusivityApril 2032latest FDA-listed patent expiry
CompanyCumberland →See this company's full patent-cliff portfolio

Drug detail

Brand nameACETADOTE
Active ingredientACETYLCYSTEINE
Strength6GM/30ML (200MG/ML)
Dosage formINJECTABLE
RouteINTRAVENOUS
ModalitySmall molecule
FDA approvalJanuary 2004
Marketing statusRX

Listed patents

PatentExpiresType
8722738April 2032use U-1373
9327028July 2031use U-1839
8148356May 2026product

Regulatory exclusivity

CodeExpires
D-196November 2027

More from Cumberland

Source: FDA Orange Book, layered on the CliffBio company graph. Cliff dates are the latest FDA-listed patent expiry; estimates are projections, not legal advice.

ACETADOTE patent cliff — loss of exclusivity April 2032 | CliffBio